| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 515.02B | 507.60B | 489.01B | 435.79B | 361.50B | 417.51B |
| Gross Profit | 154.28B | 151.31B | 140.10B | 108.04B | 90.52B | 165.25B |
| EBITDA | 102.71B | 100.82B | 90.53B | 59.77B | 47.09B | 54.16B |
| Net Income | 64.03B | 62.87B | 55.65B | 33.13B | 22.41B | 29.07B |
Balance Sheet | ||||||
| Total Assets | 629.24B | 594.98B | 570.99B | 497.08B | 454.67B | 428.65B |
| Cash, Cash Equivalents and Short-Term Investments | 233.41B | 257.47B | 254.71B | 186.01B | 177.92B | 159.54B |
| Total Debt | 3.26B | 3.40B | 3.56B | 3.75B | 3.95B | 3.93B |
| Total Liabilities | 111.84B | 101.33B | 96.46B | 92.33B | 87.52B | 85.33B |
| Stockholders Equity | 504.48B | 481.19B | 462.32B | 392.18B | 354.88B | 331.46B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 49.01B | 51.84B | 28.66B | 20.66B | 31.82B |
| Operating Cash Flow | 0.00 | 78.78B | 70.50B | 42.03B | 33.29B | 47.78B |
| Investing Cash Flow | 0.00 | -40.06B | -53.74B | -25.20B | -27.31B | -49.98B |
| Financing Cash Flow | 0.00 | -43.54B | -12.71B | -9.62B | -9.60B | -8.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥1.13T | 13.07 | 13.07% | 1.82% | 3.64% | 5.31% | |
73 Outperform | ¥415.82B | 10.77 | 10.18% | 2.56% | 3.87% | 29.64% | |
66 Neutral | ¥894.55B | 12.71 | 9.77% | 2.41% | 1.46% | -2.17% | |
63 Neutral | ¥694.25B | 15.19 | 6.04% | 2.04% | 5.55% | 27.03% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥1.07T | 13.62 | 5.97% | 2.96% | 2.79% | -6.46% | |
61 Neutral | ¥4.48T | 20.92 | 9.46% | 1.32% | 1.99% | -18.79% |